España
India
Italia
대한민국
日本
My Account
Benzinga Edge
Benzinga Research
Benzinga Pro
Login
Get Benzinga Pro
Data & APIs
Events
Premarket
Advertise
Contribute
España
India
Italia
대한민국
日本
Login
Register
Our Services
News
Earnings
Guidance
Dividends
M&A
Buybacks
Legal
Interviews
Management
Offerings
IPOs
Insider Trades
Biotech/FDA
Politics
Healthcare
Markets
Pre-Market
After Hours
Movers
ETFs
Forex
Cannabis
Commodities
Binary Options
Bonds
Futures
CME Group
Global Economics
Mining
Previews
Small-Cap
Real Estate
Penny Stocks
Digital Securities
Volatility
Options
Ratings
Analyst Color
Downgrades
Upgrades
Initiations
Price Target
Ideas
Trade Ideas
Long Ideas
Short Ideas
Technicals
From The Press
Jim Cramer
Rumors
Whisper Index
Stock of the Day
Best Stocks & ETFs
Best Penny Stocks
Best S&P 500 ETFs
Best Swing Trade Stocks
Best Blue Chip Stocks
Best High-Volume Penny Stocks
Best Small Cap ETFs
Best Stocks to Day Trade
Best REITs
Money
Investing
Cryptocurrency
Mortgage
Insurance
Yield
Personal Finance
Forex
Startup Investing
Real Estate Investing
Prop Trading
Credit Cards
Stock Brokers
Crypto
News
Earnings
Guidance
Dividends
M&A
Buybacks
Legal
Interviews
Management
Offerings
IPOs
Insider Trades
Biotech/FDA
Politics
Healthcare
Markets
Pre-Market
After Hours
Movers
ETFs
Forex
Cannabis
Commodities
Binary Options
Bonds
Futures
CME Group
Global Economics
Mining
Previews
Small-Cap
Real Estate
Penny Stocks
Digital Securities
Volatility
Options
Ratings
Analyst Color
Downgrades
Upgrades
Initiations
Price Target
Ideas
Trade Ideas
Long Ideas
Short Ideas
Technicals
From The Press
Jim Cramer
Rumors
Whisper Index
Stock of the Day
Best Stocks & ETFs
Best Penny Stocks
Best S&P 500 ETFs
Best Swing Trade Stocks
Best Blue Chip Stocks
Best High-Volume Penny Stocks
Best Small Cap ETFs
Best Stocks to Day Trade
Best REITs
Money
Investing
Cryptocurrency
Mortgage
Insurance
Yield
Personal Finance
Forex
Startup Investing
Real Estate Investing
Prop Trading
Credit Cards
Stock Brokers
Crypto
Research
My Stocks
Tools
Free Benzinga Pro Trial
Calendars
Analyst Ratings Calendar
Conference Call Calendar
Dividend Calendar
Earnings Calendar
Economic Calendar
FDA Calendar
Guidance Calendar
IPO Calendar
M&A Calendar
SPAC Calendar
Stock Split Calendar
Trade Ideas
Free Stock Reports
Insider Trades
Trade Idea Feed
Analyst Ratings
Unusual Options Activity
Heatmaps
Free Newsletter
Government Trades
Perfect Stock Portfolio
Easy Income Portfolio
Short Interest
Most Shorted
Largest Increase
Largest Decrease
Calculators
Margin Calculator
Forex Profit Calculator
100x Options Profit Calculator
Screeners
Stock Screener
Top Momentum Stocks
Top Quality Stocks
Top Value Stocks
Top Growth Stocks
Recent
Markets
oops!
The page you were looking for could not be found...
SYMBOL SIMILAR TO: EGLE
No similar symbols found
TOP GAINING STOCKS
MURA
Mural Oncology
$2.43
135.92%
SKYE
Skye Bioscience
$2.94
124.42%
SNYR
Synergy CHC
$3.13
74.58%
ARBB
ARB IOT Group
$1.00
54.61%
BUJAR
Bukit Jalil Global Acquisition 1 Ltd. - Rights
$0.28
53.00%
Session: Apr 14, 2025 4:00PM EDT - Apr 15, 2025 10:02AM EDT
Popular News
Bessent Says Tariffs On China Are 'Far From A Joke,' Dismisses Treasury Dumping Fears
Bank of America CEO Says Consumer Continues To Spend And Maintain Healthy Credit Quality, Sticks To Annual Outlook
This Strategy Outperforms In Bear Markets
The S&P 500 Closes With First 'Death Cross' Since 2022 - Here's What It Means For The Markets
US Stock Futures Waver After Two-Day Rally: Trump's Tariff Moves Could End A 3-Year 'Rolling Recession,' Says Expert
Asia And Europe Markets Gain On Reduced Uncertainty, Gold Holds Near Highs - Global Markets Today While US Slept
Jensen Huang Praised By Trump: Nvidia 'Wouldn't Be Doing' $500 Billion AI Infrastructure Commitment Without Tariffs
Shiba Inu's Burn Rate Fires 1734% But Traders Are Still Betting Against The Memecoin—What You Need To Know
5 Small Businesses Hit Trump With Lawsuit Over Tariffs: Trade Deficits 'Are Not An Emergency'
Federal Tax Return Deadline Looms: What To Know About Extensions, Payments, Late Filings
A US Recession In 2025? Betting Odds Say It's More Likely Than Not
'No Expiration Date' On Meta's Antitrust Case, Says Former FTC Chair As Trial Begins
